Role of Low Dose Injectable Progesterone in Triggering Ovulation

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age20-35
SponsorThe General Authority for Teaching Hospitals and Institutes

About this trial

The aim of this study is to evaluate the role of low dose injectable progesterone in triggering ovulation.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age from 20 to 35 years.

Infertile women.

Basal follicle-stimulating hormone (FSH) level <10 mIU/ml.

Disqualifiers

Poor ovarian reserve.

Immunological disease.

Endometriosis.

Uterine abnormality.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Progesterone

    Drug

    Women will receive low dose progesterone 5 mg intramuscularly as a study group. (Letrozole 2.5 mg/day will be given from cycle day 3 onwards for only 5 days).

  • Placebo

    Drug

    Women will receive placebo as a control group. (Placebo 2.5 mg/day will be given from cycle day 3 onwards for only 5 days).

Treatment groups

120 Participants
are divided into 2 treatment groups
Group A: Progesterone groupExperimental treatment 1 intervention
Group B: Control groupPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

Incidence of ovulation rates

Incidence of ovulation rates will be recorded.

Time frame
10-12 days of the menstrual cycle

Secondary outcomes

1

Follicle stimulating hormone (FSH)levels

Follicle stimulating hormone (FSH) will be measured on day 3, day 8-10 and day 10-12 of the menstrual cycle, as well as the day of trigger and oocyte retrieval.

Time frame
10-12 days of the menstrual cycle
2

Luteinizing hormone (LH)levels

Luteinizing hormone (LH) will be measured on day 3, day 8-10 and day 10-12 of the menstrual cycle, as well as the day of trigger and oocyte retrieval).

Time frame
10-12 days of the menstrual cycle
3

Estradiol (E2) levels

Estradiol (E2) will be measured on day 3, day 8-10 and day 10-12 of the menstrual cycle, as well as the day of trigger and oocyte retrieval.

Time frame
10-12 days of the menstrual cycle
4

Progesterone levels

Progesterone levels will be measured on day 3, day 8-10 and day 10-12 of the menstrual cycle, as well as the day of trigger and oocyte retrieval.

Time frame
10-12 days of the menstrual cycle

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.